Published in
Springer (part of Springer Nature), Cancer Immunology, Immunotherapy, 4(71), p. 865-874, 2021
DOI: 10.1007/s00262-021-03045-9
Links
Tools
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
Journal article published in 2021 by
Marco Russano 
,
Alessio Cortellini ,
Raffaele Giusti ,
Alessandro Russo ,
Federica Zoratto,
Francesca Rastelli,
Alain Gelibter,
Rita Chiari ,
Olga Nigro ,
Michele De Tursi ,
Sergio Bracarda,
Stefania Gori ,
Francesco Grossi ,
Melissa Bersanelli ,
Lorenzo Calvetti
and other authors.
,
Alessio Cortellini ,
Raffaele Giusti ,
Alessandro Russo ,
Federica Zoratto,
Francesca Rastelli,
Alain Gelibter,
Rita Chiari ,
Olga Nigro ,
Michele De Tursi ,
Sergio Bracarda,
Stefania Gori ,
Francesco Grossi ,
Melissa Bersanelli ,
Lorenzo Calvetti
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 